I like this part! "Promising early-stage techno
Post# of 9122
"Promising early-stage technologies will initially move to Phase I, where NIH will make a modest award of funds while simultaneously supporting that inventor or company with technical and clinical experts, Collins said."
This may incentivise potential partners to license NNLX tech.